Finance

Lists
2493:HKG
Mabwell (Shanghai) Bioscience Co Ltd
HK$20.88
+0.87%
(+0.18) 1D
Oct 2, 4:08:07 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2493...
Open
HK$21.80
High
HK$21.80
Low
HK$19.86
Mkt. cap
11.64B
Avg. vol.
242.39K
Volume
75.80K
52-wk high
HK$31.46
52-wk low
HK$19.86
Shares outstanding
47.13M
No. of employees
1K
Open
HK$21.80
High
HK$21.80
Low
HK$19.86
Mkt. cap
11.64B
Avg. vol.
242.39K
Volume
75.80K
52-wk high
HK$31.46
52-wk low
HK$19.86
Shares outstanding
47.13M
No. of employees
1K
News stories
From web sources and news partners
About Mabwell (Shanghai) Bioscience Co Ltd
CEO-
Employees1.36K
FoundedMay 12, 2017
Headquarters-
SectorBiotechnology
Websitemabwell.com
Last report
Aug 30, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
185.04M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
464.67M
96.68M
127.60M
185.04M
Cost of goods sold
9.54M
36.95M
30.43M
46.76M
Cost of revenue
9.54M
36.95M
30.43M
46.76M
Research and development expenses
320.06M
264.81M
164.50M
266.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128.26M
148.32M
130.20M
112.79M
Operating expense
422.51M
442.06M
301.93M
375.57M
Total operating expenses
432.04M
479.02M
332.36M
422.34M
Operating income
32.63M
-382.34M
-204.76M
-237.29M
Other non operating income
-5.04M
5.06M
-2.90M
-466.34K
EBT including unusual items
-30.50M
-373.72M
-240.15M
-283.66M
EBT excluding unusual items
7.18M
-407.47M
-234.55M
-279.64M
Income tax expense
16.86M
-1.06M
2.89M
-2.50M
Effective tax rate
-55.29%
0.28%
-1.20%
0.88%
Other operating expenses
-22.84M
25.11M
304.47K
2.17M
Net income
-46.34M
-371.67M
-241.94M
-279.76M
Net profit margin
-9.97%
-384.45%
-189.62%
-151.19%
Earnings per share
-
-
-
-
Interest and investment income
1.65M
2.54M
2.06M
3.45M
Interest expense
-22.37M
-29.17M
-28.94M
-30.84M
Net interest expenses
-20.72M
-26.63M
-26.88M
-27.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
56.84M
-337.10M
-159.52M
-191.50M
Gain or loss from assets sale
-
-199.41K
-
-299.58K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps